
Abcam plc ABCM
Annual report 2022
added 12-28-2024
Abcam plc P/CF Ratio 2011-2026 | ABCM
Annual P/CF Ratio Abcam plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 84.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.9 | 84.9 | 84.9 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 8.61 | -0.35 % | $ 85.1 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.73 | 1.78 % | $ 8.97 B | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 98.83 | 2.2 % | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 4.68 | 4.34 % | $ 760 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 3.25 | 1.41 % | $ 327 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 21.47 | 0.51 % | $ 1 B | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Clearside Biomedical
CLSD
|
-5.59 | - | - | $ 25.3 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.53 | 3.74 % | $ 393 M | ||
|
Evogene Ltd.
EVGN
|
-2.68 | $ 0.83 | 0.91 % | $ 27.9 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Forte Biosciences
FBRX
|
-6.59 | $ 32.98 | 7.76 % | $ 427 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.05 | 4.45 % | $ 5.02 M | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.13 | -1.43 % | $ 442 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 25.25 | 4.68 % | $ 3.21 B | ||
|
Chimerix
CMRX
|
-1.5 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-1.87 | - | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-9.67 | $ 33.25 | 2.03 % | $ 2.21 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.49 | 1.02 % | $ 397 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
-0.84 | - | - | $ 1.41 B | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.45 | 4.26 % | $ 157 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.0767 | $ 2.51 | - | $ 1.11 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B |